Vaccinex, Inc.

VCNX

Financials

10-KFY 202404/15/25 10-QQ3 ended 09/30/2411/14/24 10-QQ2 ended 06/30/2408/14/24 10-QQ1 ended 03/31/2405/15/24 10-K/AFY 202304/25/24

Disclosures

8-KCurrent report03/19/25 8-KCurrent report03/07/25 8-KCurrent report12/17/24 8-KCurrent report11/14/24 8-KCurrent report10/09/24

Prospectuses and Registrations

POS AMPost-effective amendment03/25/25 POS AMPost-effective amendment03/25/25 POS AMPost-effective amendment03/25/25 POS AMPost-effective amendment03/25/25 POS AMPost-effective amendment03/25/25

Proxies

DEF 14ADefinitive proxy04/02/24 DEF 14ADefinitive proxy01/08/24 PRE 14APreliminary proxy12/28/23 DEF 14ADefinitive proxy08/14/23 PRE 14APreliminary proxy08/04/23

Ownership

SC 13G/ABeneficial ownership (amended)02/14/25 Form 4Insider transaction11/18/24 Form 4Insider transaction11/18/24 SC 13D/ABeneficial ownership (amended)11/18/24 SC 13GBeneficial ownership11/14/24

Other

NT 10-KLate filing notification (10-K)04/01/25 15-12GCertification of termination of registration03/27/25 EFFECTRequest for effectiveness03/25/25 EFFECTRequest for effectiveness03/25/25 EFFECTRequest for effectiveness03/25/25